Alpha Tau Medical Ltd. (DRTS) Income Statement Analysis - Revenue, Earnings & Profitability Metrics - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Alpha Tau Medical Ltd.

    NASDAQ: DRTS · Real-Time Price · USD
    3.60
    0.11 (3.15%)
    At close: Sep 05, 2025, 3:59 PM
    3.60
    0.00%
    Pre-market: Sep 08, 2025, 08:00 AM EDT

    Alpha Tau Medical Income Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Revenue
    		 n/a n/a n/a n/a
    Cost of Revenue
    		 1.1M 1.07M 979K 776K
    Gross Profit
    		 -1.1M -1.07M -979K -776K
    Operating Income
    		 -36.04M 35.68M -32.14M -13.79M
    Interest Income
    		 4.28M 4.75M 1.79M 211K
    Pretax Income
    		 -31.74M -29.14M -33.74M -27.26M
    Net Income
    		 -31.75M -29.16M -33.76M -27.27M
    Selling & General & Admin
    		 7.92M 9.26M 11.25M 2.34M
    Research & Development
    		 27.02M 26.42M 20.89M 11.45M
    Other Expenses
    		 n/a -72.2M n/a n/a
    Operating Expenses
    		 34.94M -35.68M 32.14M 13.79M
    Interest Expense
    		 344K 39K 1.77M 13.27M
    Selling & Marketing Expenses
    		 1.25M 1.92M 974K 482K
    Cost & Expenses
    		 -36.04M -35.68M 32.14M 13.79M
    Income Tax Expense
    		 6K 16K 20K 7K
    Shares Outstanding (Basic)
    		 69.93M 69.38M 63.53M 40.53M
    Shares Outstanding (Diluted)
    		 69.93M 69.38M 63.53M 40.53M
    EPS (Basic)
    		 -0.45 -0.42 -0.53 -0.67
    EPS (Diluted)
    		 -0.45 -0.42 -0.53 -0.67
    EBITDA
    		 -30.3M -28.03M -32.74M -13.21M
    EBIT
    		 -31.4M -29.1M -33.72M -13.99M
    Depreciation & Amortization
    		 1.1M 1.07M 979K 776K

    Add to Watchlist